{
  "@context": "aku-v2",
  "@type": "pathology",
  "@id": "vasc:lm:gla",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:48:00.000Z",
    "updated": "2026-01-07T03:48:00.000Z",
    "contributors": ["vascular-surgery-agent"],
    "confidence": 0.82,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/vascular-malformations",
    "type": "lymphatic-anomaly",
    "difficulty": "advanced",
    "importance": "low"
  },
  "content": {
    "title": "Generalized Lymphatic Anomaly",
    "description": "Rare disorder with diffuse lymphatic malformations affecting multiple organs including bone, soft tissue, and viscera.",
    "clinical_features": {
      "distribution": "Multifocal lymphatic lesions",
      "bone_involvement": "Lytic bone lesions (unlike Gorham - no progressive destruction)",
      "visceral": ["Spleen", "Liver", "Mediastinum"]
    },
    "complications": {
      "chylous_effusions": "Chylothorax, chylous ascites, pericardial effusion",
      "bone_complications": "Pathologic fractures"
    },
    "treatment": {
      "medical": "Sirolimus shows benefit",
      "supportive": "Drainage of effusions, nutritional support",
      "surgical": "Limited role"
    },
    "clinical_pearl": "Unlike Gorham-Stout, bone lesions are stable; sirolimus increasingly used as systemic therapy"
  },
  "relationships": {
    "related_concepts": ["vasc:gorham-stout", "vasc:lymphatic-malformation", "vasc:chylothorax"]
  },
  "provenance": {
    "primary_sources": [{"type": "textbook", "title": "Standard vascular surgery reference", "year": 2023}],
    "validation_status": "peer-reviewed"
  }
}
